Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Precision Medicine in Action: The Impact of Ivacaftor on Cystic Fibrosis-Related Hospitalizations

Precision Medicine in Action: The Impact of Ivacaftor on Cystic Fibrosis-Related Hospitalizations

Resource Type

CF Research News

Authors

Feng LB, Grosse SD, Green RF, Fink AK, Sawicki GS

References

Health Aff (Millwood). 2018 May;37(5):773-779. doi: 10.1377/hlthaff.2017.1554.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Precision medicine [3]
Rare disease [4]
real world evidence [5]

Date

Tuesday, May 15, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/precision-medicine-action-impact-ivacaftor-cystic-fibrosis-related

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/Feng%202018.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Precision%20Medicine%20in%20Action%3A%20The%20Impact%20of%20Ivacaftor%20on%20Cystic%20Fibrosis-Related%20Hospitalizations [3] https://www.ecfs.eu/research-article-keywords/precision-medicine [4] https://www.ecfs.eu/research-article-keywords/rare-disease [5] https://www.ecfs.eu/research-article-keywords/real-world-evidence [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines